Illumina shares jump as Q3 earnings beat expectations, guidance raised By Investing.com
Update: 2025-10-30
Description
Illumina's Q3 results exceeded expectations, with adjusted earnings per share of $1.34 and revenue of $1.08 billion. The company's clinical segment drove growth, and operating margin improved to 24.5%. Strong cash flow allowed for $120 million in share buybacks. Illumina raised its full-year 2025 revenue guidance, expecting a decline of less than 1.5% (0.5-1.5% outside of China) and adjusted earnings per share of $4.65-$4.75.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
